Bank J. Safra Sarasin has acquired the entirety of MIV Asset Management in a move that underscores its commitment to growing its asset management business. 

MIV is known for its expertise in medical technology (medtech) investments via its flagship MIV GlobalMedtech Fund.

Oliver Cartade, head of asset management and institutional clients division at Bank J. Safra Sarasin, said: “We are thrilled to welcome MIV Asset Management into the J. Safra Sarasin Group. This acquisition aligns perfectly with our strategic vision to strengthen our thematic equity offerings and underscores our commitment to providing clients with unparalleled investment opportunities.

“MIV’s exceptional team and proven track record will be instrumental in driving our growth and innovation in the thematic investing space.

Christoph Gubler, senior portfolio manager and chief executive officer of MIV Asset Management, said: “We are excited to become part of the J. Safra Sarasin Group to ensure the long-term success of our investment strategy in the best interest of investors. We look forward to continuing our success story as part of the J. Safra Sarasin Group.”

Financial terms of the transaction were not disclosed.

The latest digital edition of IPE’s magazine is now available

Topics